Literature DB >> 24844043

Combating the prescription painkiller epidemic: a national prescription drug reporting program.

Joanna Shepherd.   

Abstract

Prescription painkiller abuse is the fastest growing drug problem in the United States. In the past year, approximately one out of twenty Americans reported misuse or abuse of prescription painkillers. Several factors contribute to the prescription painkiller epidemic. Drug abusers use various methods--such as doctor shopping, paying with cash, and filling prescriptions in different states--to avoid detection and obtain prescription painkillers for illegitimate uses. A few rogue physicians and pharmacists, lured by substantial profits, enable drug abusers by illegally prescribing or supplying controlled substances. Even ethical physicians rarely have adequate training to recognize and address prescription drug abuse, and as a result, prescribe painkillers to patients who are not using them for legitimate medical purposes. Similarly, although the majority of pharmacies have taken steps to combat drug abuse and reduce prescription painkiller dispensing, under current reporting systems, pharmacists lack visibility into several important indicators of drug abuse. As a result, even the most vigilant pharmacists find it extremely difficult to identify and detect drug abuse with certainty. While state governments have established prescription drug monitoring programs (PDMPs) to crack down on prescription drug abuse, these programs have proven to be inadequate. The programs currently suffer from inadequate data collection, ineffective utilization of data, insufficient interstate data sharing, and constraints on sharing data with law enforcement and state agencies. By contrast, third-party prescription payment systems run by pharmacy benefit managers (PBMs) or health insurers have been effective in detecting prescription drug abuse. This paper suggests that a national prescription drug reporting program building on existing PBM networks could be significantly more effective than existing state PDMPs in detecting prescription drug abuse.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24844043     DOI: 10.1177/009885881404000103

Source DB:  PubMed          Journal:  Am J Law Med        ISSN: 0098-8588


  9 in total

1.  Prescription Drug Monitoring Programs.

Authors:  Michael Gabay
Journal:  Hosp Pharm       Date:  2015-04-08

2.  Reducing Opioid Misuse: Evaluation of a Medicaid Controlled Substance Lock-In Program.

Authors:  Asheley Cockrell Skinner; Chris Ringwalt; Rebecca B Naumann; Andrew W Roberts; Leslie A Moss; Nidhi Sachdeva; Mark A Weaver; Joel Farley
Journal:  J Pain       Date:  2016-08-04       Impact factor: 5.820

Review 3.  Current State of Opioid Therapy and Abuse.

Authors:  Laxmaiah Manchikanti; Adam M Kaye; Alan D Kaye
Journal:  Curr Pain Headache Rep       Date:  2016-05

4.  Nonmedical Prescription Opioid Use in Childhood and Early Adolescence Predicts Transitions to Heroin Use in Young Adulthood: A National Study.

Authors:  Magdalena Cerdá; Julián Santaella; Brandon D L Marshall; June H Kim; Silvia S Martins
Journal:  J Pediatr       Date:  2015-06-06       Impact factor: 4.406

5.  Effectiveness of Remote Intensive Counseling Versus Outpatient Counseling in Substance Use Disorders: A Retrospective Cohort Study.

Authors:  Armand Ntchana; Ricky Daley
Journal:  Cureus       Date:  2022-04-15

6.  Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014.

Authors:  Silvia S Martins; Luis E Segura; Julian Santaella-Tenorio; Alexander Perlmutter; Miriam C Fenton; Magdalena Cerdá; Katherine M Keyes; Lilian A Ghandour; Carla L Storr; Deborah S Hasin
Journal:  Addict Behav       Date:  2016-08-30       Impact factor: 3.913

7.  Factors influencing use of analgesics among construction workers in the Ga-Eastmunicipality of the Greater Accra region, Ghana.

Authors:  Caroline D Badzi; Mercy M Ackumey
Journal:  Ghana Med J       Date:  2017-12

Review 8.  Prescription opioid abuse: pharmacists' perspective and response.

Authors:  Gerald Cochran; Valerie Hruschak; Brooke DeFosse; Kenneth C Hohmeier
Journal:  Integr Pharm Res Pract       Date:  2016-08-25

9.  Reviewing opioid use, monitoring, and legislature: Nursing perspectives.

Authors:  Deniece A Jukiewicz; Aisha Alhofaian; Zenora Thompson; Faye A Gary
Journal:  Int J Nurs Sci       Date:  2017-09-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.